Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RLMDRELMADA THERAPEUTICS, INC.

Nasdaq · CIK 0001553643
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts482

Identity from submissions API

NameRELMADA THERAPEUTICS, INC.
CIK0001553643
TickersRLMD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN455401931
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone646 876 3459
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CAMP NINE, INC. (2012-11-13T05:00:00.000Z → 2014-07-14T04:00:00.000Z)
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR
CORAL GABLES
FL
33134
FL
Mailing address
2222 PONCE DE LEON BLVD. 3RD FLOOR
CORAL GABLES
FL
33134
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

610 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002050709-26-000032 005-88207 261558231 34 80859
2026-11-16 8-K CURRENT REPORT 7.01,9.01 0001213900-26-120144 001-39082 261555532 34 245168 1 1
2026-11-12 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-118933 001-39082 261547024 34 12647057 1 1
2026-11-12 10-Q QUARTERLY REPORT 0001213900-26-118916 001-39082 261546877 34 4737300 1 1
2026-09-11 4 OWNERSHIP DOCUMENT 0001213900-26-098970 6966
2026-09-11 4 xslF345X06/ownership.xml 0001213900-26-098969 7112
2026-09-08 8-K CURRENT REPORT 8.01 0001213900-26-097851 001-39082 261363437 34 187941 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002050709-26-000025 005-88207 261279212 34 81089
2026-08-06 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-086190 001-39082 261249915 34 12625118 1 1
2026-08-06 10-Q QUARTERLY REPORT 0001213900-26-086151 001-39082 261249254 34 4832299 1 1
2026-07-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002872 005-88207 261216935 34 10901
2026-07-28 8-K CURRENT REPORT 7.01,9.01 0001213900-26-082007 001-39082 261207629 34 237185 1 1
2026-06-22 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-076490 005-88207 261108199 34 16183
2026-06-18 S-8 REGISTRATION STATEMENT 0001213900-26-070097 333-296895 261102522 33 534036 1 1
2026-06-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001738048-26-000066 005-88207 261077656 34 35012
2026-05-28 8-K CURRENT REPORT 5.03,5.07,9.01 0001213900-26-062184 001-39082 261037581 34 2474221 1 1
2026-05-13 S-3ASR REGISTRATION STATEMENT 0001213900-26-055901 333-295855 26974276 33 558975 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002929 005-88207 26971248 34 12645
2026-05-12 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-055164 001-39082 26969629 34 16264770 1 1
2026-05-12 10-Q QUARTERLY REPORT 0001213900-26-055059 001-39082 26968450 34 4137539 1 1
2026-05-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000017 005-88207 26938066 34 15340
2026-04-17 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-26-045194 001-39082 26872026 34 4096120
2026-04-17 DEF 14A PROXY STATEMENT 0001213900-26-045192 001-39082 26872006 34 7420859 1 1
2026-04-09 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001136 333-294885 26853029 33 1843
2026-04-09 424B3 PROSPECTUS 0001213900-26-042007 333-294885 26851867 33 200706
2026-04-07 CORRESP filename1.htm 0001213900-26-040821 6463
2026-04-07 UPLOAD filename1.pdf 0000000000-26-003470 333-294885 40198
2026-04-06 PRE 14A PROXY STATEMENT 0001213900-26-040498 001-39082 26841715 34 7309871 1 1
2026-04-03 S-3 REGISTRATION STATEMENT 0001213900-26-039967 333-294885 26838531 33 4127098 1 1
2026-03-20 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-26-032403 001-39082 26778890 34 12155119 1 1
2026-03-19 10-K ANNUAL REPORT 0001213900-26-031862 001-39082 26774581 34 5418627 1 1
2026-03-09 8-K CURRENT REPORT 1.01,3.02,7.01,8.01,9.01 0001213900-26-024918 001-39082 26733168 34 9057252 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002050709-26-000007 005-88207 26638712 34 81438
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001027 005-88207 26637036 34 15690
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000914 005-88207 26623716 34 15966
2026-02-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000046 005-88207 26608172 34 12350
2026-01-30 424B5 PROSPECTUS SUPPLEMENT 0001213900-26-010313 333-281877 26584528 33 27407
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121974 7662
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121973 7008
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121972 5444
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121971 5507
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121969 5485
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121968 5460
2025-12-16 4 xslF345X05/ownership.xml 0001213900-25-121967 5456
2025-12-15 8-K CURRENT REPORT 5.02,9.01 0001213900-25-121461 001-39082 251570054 34 617368 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-283441 005-88207 251488675 34 155318
2025-11-13 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-110088 001-39082 251479492 34 6750423 1 1
2025-11-13 10-Q QUARTERLY REPORT 0001213900-25-109983 001-39082 251478444 34 4117170 1 1
2025-11-06 4 xslF345X05/ownership.xml 0001213900-25-106836 4625
2025-11-06 4 xslF345X05/ownership.xml 0001213900-25-106838 4596
2025-11-06 4 xslF345X05/ownership.xml 0001213900-25-106837 4619
2025-11-06 4 xslF345X05/ownership.xml 0001213900-25-106835 4629
2025-11-05 8-K CURRENT REPORT 1.01,7.01,9.01 0001213900-25-106398 001-39082 251451503 34 675523 1 1
2025-11-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-106396 333-281877 251451501 33 462385
2025-11-04 FWP FREE WRITING PROSPECTUS 0001213900-25-105641 333-281877 251446578 34 81751
2025-11-04 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-105593 001-39082 251446377 34 27366074 1 1
2025-09-17 8-K CURRENT REPORT 7.01,9.01 0001213900-25-088360 001-39082 251318789 34 21827287 1 1
2025-09-16 8-K CURRENT REPORT 8.01,9.01 0001213900-25-087926 001-39082 251315863 34 210111 1 1
2025-09-10 8-K CURRENT REPORT 7.01,9.01 0001213900-25-086389 001-39082 251304750 34 8799405 1 1
2025-09-02 8-K CURRENT REPORT 7.01 0001213900-25-082910 001-39082 251282944 34 190150 1 1
2025-08-28 4 xslF345X05/ownership.xml 0001213900-25-081837 8640
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002050709-25-000005 005-88207 251221123 34 78391
2025-08-07 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-25-073130 001-39082 251195163 34 22048136 1 1
2025-08-07 10-Q QUARTERLY REPORT 0001213900-25-073073 001-39082 251193915 34 3881080 1 1
2025-07-23 8-K CURRENT REPORT 3.01 0001213900-25-066995 001-39082 251143437 34 196962 1 1
2025-07-10 8-K CURRENT REPORT 1.02 0001213900-25-062803 001-39082 251116613 34 190727 1 1
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059870 5433
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059869 5465
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059868 5458
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059867 5442
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059866 5474
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059865 5496
2025-06-30 4 xslF345X05/ownership.xml 0001213900-25-059864 5469
2025-06-18 8-K CURRENT REPORT 7.01,9.01 0001213900-25-055334 001-39082 251054721 34 220416 1 1
2025-06-13 S-8 REGISTRATION STATEMENT 0001213900-25-053957 333-287991 251044297 33 390645
2025-05-27 8-K CURRENT REPORT 5.07,9.01 0001213900-25-047805 001-39082 25988566 34 200415 1 1
2025-05-20 4 xslF345X05/ownership.xml 0001213900-25-046088 5326
2025-05-20 4 xslF345X05/ownership.xml 0001213900-25-046087 8662
2025-05-20 4 xslF345X05/ownership.xml 0001213900-25-046086 5289
2025-05-20 4 xslF345X05/ownership.xml 0001213900-25-046085 8651
2025-05-12 10-Q QUARTERLY REPORT 0001213900-25-042025 001-39082 25934760 34 4126950 1 1
2025-05-12 8-K CURRENT REPORT 4.01,9.01 0001213900-25-042024 001-39082 25934752 34 222414 1 1
2025-05-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002050709-25-000003 005-88207 25903468 34 78103
2025-04-28 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-035961 333-281877 25878954 33 30855
2025-04-28 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-035941 001-39082 25878721 34 254670 1 1
2025-04-11 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-031095 001-39082 25832297 34 3905848
2025-04-11 DEF 14A PROXY STATEMENT 0001213900-25-031088 001-39082 25832273 34 7864026 1 1
2025-03-27 8-K CURRENT REPORT 2.02,9.01 0001013762-25-003432 001-39082 25780078 34 307127 1 1
2025-03-27 10-K ANNUAL REPORT 0001013762-25-003426 001-39082 25780048 34 5293118 1 1
2025-03-26 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001013762-25-002786 001-39082 25774126 34 247482 1 1
2025-02-06 8-K CURRENT REPORT 1.01,7.01,8.01,9.01 0001213900-25-010711 001-39082 25595366 34 378029 1 1
2025-01-27 8-K CURRENT REPORT 3.01 0001213900-25-006727 001-39082 25555779 34 204822 1 1
2025-01-06 8-K CURRENT REPORT 5.02,9.01 0001213900-25-001249 001-39082 25512486 34 781828 1 1
2024-12-09 8-K CURRENT REPORT 7.01,9.01 0001213900-24-106646 001-39082 241533873 34 240706 1 1
2024-12-04 8-K CURRENT REPORT 7.01,9.01 0001213900-24-105245 001-39082 241524806 34 223563 1 1
2024-11-14 SC 13G/A deeptrack-rlmd093024a3.htm 0001172661-24-004766 005-88207 241457872 34 103509
2024-11-07 10-Q QUARTERLY REPORT 0001213900-24-095398 001-39082 241435546 34 3482889 1 1
2024-10-23 4 xslF345X05/ownership.xml 0001213900-24-089971 4603
2024-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-12 16:30:00 9999999995-24-002821 333-281877 241296358 33 1851
2024-09-11 4 OWNERSHIP DOCUMENT 0001213900-24-077795 8677
2024-09-11 4 xslF345X05/ownership.xml 0001213900-24-077794 4610
2024-09-11 4 xslF345X05/ownership.xml 0001213900-24-077792 8648
2024-09-11 4 xslF345X05/ownership.xml 0001213900-24-077791 5304
2024-09-11 CORRESP filename1.htm 0001213900-24-077748 6282
2024-09-06 UPLOAD filename1.pdf 0000000000-24-010111 333-281877 40188
2024-08-30 S-3 REGISTRATION STATEMENT 0001213900-24-074553 333-281877 241270416 33 650560
2024-08-07 10-Q QUARTERLY REPORT 0001213900-24-066111 001-39082 241183587 34 3168963 1 1
2024-05-30 8-K CURRENT REPORT 5.07,9.01 0001213900-24-047968 001-39082 241005189 34 215179 1 1
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047639 8515
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047638 8516
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047637 8497
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047636 8524
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047635 8546
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047633 8484
2024-05-29 4 xslF345X05/ownership.xml 0001213900-24-047632 8495
2024-05-08 10-Q QUARTERLY REPORT 0001213900-24-040856 001-39082 24925877 34 3062454 1 1
2024-04-09 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-24-031609 001-39082 24832889 34 3976310
2024-04-09 DEF 14A PROXY STATEMENT 0001213900-24-031600 001-39082 24832826 34 4847937
2024-03-19 8-K CURRENT REPORT 2.02,9.01 0001213900-24-024022 001-39082 24763286 34 340159 1 1
2024-03-19 10-K ANNUAL REPORT 0001213900-24-024013 001-39082 24763060 34 4604930 1 1
2024-03-06 SC 13G/A SC 13G/A 0001193125-24-060735 005-88207 24726072 34 65439
2024-02-20 144 xsl144X01/primary_doc.xml 0001972362-24-000160 001-39082 24655353 33 4355
2024-02-14 SC 13G/A deeptrack-rlmd123123a2.htm 0001172661-24-000937 005-88207 24632710 34 103424
2024-02-14 SC 13G/A RELMADA THERAPEUTICS, INC. 0000902664-24-001574 005-88207 24632386 34 61791
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021823 005-88207 24629459 34 13158
2024-01-31 4 xslF345X05/ownership.xml 0001213900-24-008560 8651
2024-01-31 4 xslF345X05/ownership.xml 0001213900-24-008559 8655
2024-01-31 4 xslF345X05/ownership.xml 0001213900-24-008557 8625
2024-01-11 8-K CURRENT REPORT 5.02 0001213900-24-003000 001-39082 24529571 34 200390 1 1
2024-01-04 8-K CURRENT REPORT 7.01,9.01 0001213900-24-000999 001-39082 24509812 34 231014 1 1
2024-01-03 8-K CURRENT REPORT 5.02 0001213900-24-000858 001-39082 24507852 34 195901 1 1
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097032 5460
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097031 5464
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097029 5446
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097028 5474
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097027 5496
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097026 5447
2023-12-19 4 xslF345X05/ownership.xml 0001213900-23-097024 5444
2023-11-08 10-Q QUARTERLY REPORT 0001213900-23-084737 001-39082 231387758 34 2906445 1 1
2023-11-08 8-K CURRENT REPORT 2.02,9.01 0001213900-23-084735 001-39082 231387678 34 349761 1 1
2023-10-11 8-K CURRENT REPORT 7.01,9.01 0001013762-23-002985 001-39082 231319498 34 240735 1 1
2023-10-10 8-K CURRENT REPORT 8.01,9.01 0001013762-23-002900 001-39082 231318778 34 8165201 1 1
2023-10-04 8-K CURRENT REPORT 8.01,9.01 0001013762-23-001391 001-39082 231306660 34 13869780 1 1
2023-09-20 8-K CURRENT REPORT 7.01,9.01 0001213900-23-078049 001-39082 231266970 34 301851 1 1
2023-09-06 8-K CURRENT REPORT 5.02,9.01 0001213900-23-074165 001-39082 231238003 34 200097 1 1
2023-08-10 8-K CURRENT REPORT 8.01,9.01 0001213900-23-065674 001-39082 231160415 34 7254694 1 1
2023-08-08 8-K CURRENT REPORT 2.02,9.01 0001213900-23-064577 001-39082 231151852 34 358836 1 1
2023-08-08 10-Q QUARTERLY REPORT 0001213900-23-064519 001-39082 231151066 34 2906304 1 1
2023-07-07 SC 13G/A us75955j4022_070723.txt 0001306550-23-009606 005-88207 231077301 34 12410
2023-06-21 S-8 REGISTRATION STATEMENT 0001213900-23-050588 333-272811 231030639 33 209656
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044093 6038
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044089 6045
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044088 5984
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044087 5937
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044084 5965
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044083 6123
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044081 6014
2023-05-30 4 xslF345X04/ownership.xml 0001213900-23-044079 5935
2023-05-25 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-23-043101 001-39082 23961125 34 423834 1 1
2023-05-24 4 OWNERSHIP DOCUMENT 0001213900-23-042554 5328
2023-05-15 8-K CURRENT REPORT 8.01,9.01 0001213900-23-040004 001-39082 23924581 34 4603086 1 1
2023-05-11 8-K CURRENT REPORT 2.02,9.01 0001213900-23-038577 001-39082 23911834 34 342857 1 1
2023-05-11 10-Q QUARTERLY REPORT 0001213900-23-038533 001-39082 23910995 34 2812232 1 1
2023-04-19 8-K CURRENT REPORT 8.01,9.01 0001213900-23-030851 001-39082 23828618 34 10972687 1 1
2023-03-31 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-23-025008 001-39082 23783558 34 474245
2023-03-31 DEF 14A PROXY STATEMENT 0001213900-23-025007 001-39082 23783536 34 4801836
2023-03-23 10-K ANNUAL REPORT 0001213900-23-022463 001-39082 23756841 34 4642960 1 1
2023-03-23 8-K CURRENT REPORT 2.02,9.01 0001213900-23-022428 001-39082 23756208 34 346980 1 1
2023-03-13 8-K CURRENT REPORT 7.01 0001213900-23-019392 001-39082 23725820 34 197579 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021799 005-88207 23630744 34 75035
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-23-000385 005-88207 23629420 34 63482
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000532 005-88207 23625112 34 266128
2023-02-14 SC 13G/A RELMADA THERAPEUTICS, INC. 0000902664-23-001728 005-88207 23623873 34 62574
2023-02-14 SC 13G/A deeptrack-rlmd123122a1.htm 0001172661-23-000852 005-88207 23623092 34 103341
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020772 005-88207 23622720 34 137787
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-016835 005-88207 23604104 34 13053
2023-02-06 5/A OWNERSHIP DOCUMENT 0001213900-23-008514 20013
2023-02-02 5 OWNERSHIP DOCUMENT 0001213900-23-007440 17827
2023-02-02 5 OWNERSHIP DOCUMENT 0001213900-23-007438 12919
2023-02-02 5 OWNERSHIP DOCUMENT 0001213900-23-007436 7086
2023-02-01 SC 13G/A us75955j4022_020123.txt 0001306550-23-006526 005-88207 23577590 34 13221
2023-01-17 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-23-002865 001-39082 23529759 34 304615 1 1
2023-01-13 3 OWNERSHIP DOCUMENT 0001213900-23-002892 3039
2023-01-13 4 OWNERSHIP DOCUMENT 0001213900-23-002871 5395
2023-01-13 3 OWNERSHIP DOCUMENT 0001213900-23-002870 3681
2023-01-09 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-23-001518 001-39082 23516769 34 4504554 1 1
2023-01-05 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-23-001162 001-39082 23512551 34 262558 1 1
2022-12-28 8-K CURRENT REPORT 1.01,9.01 0001213900-22-083290 001-39082 221495598 34 222032 1 1
2022-12-20 4 xslF345X03/ownership.xml 0001213900-22-081520 5951
2022-12-20 4 xslF345X03/ownership.xml 0001213900-22-081519 5938
2022-12-20 4 xslF345X03/ownership.xml 0001213900-22-081518 5942
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081481 5426
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081479 5433
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081478 5411
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081477 5364
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081475 5392
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081474 5402
2022-12-20 4 OWNERSHIP DOCUMENT 0001213900-22-081473 5362
2022-12-20 SC 13G d9893441_13-g.htm 0000919574-22-007127 005-88207 221474583 34 70028
2022-12-12 4 xslF345X03/ownership.xml 0001213900-22-079244 5203
2022-12-07 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-22-078255 001-39082 221450728 34 4117847 1 1
2022-11-14 8-K CURRENT REPORT 8.01,9.01 0001213900-22-071463 001-39082 221379646 34 4356930 1 1
2022-11-10 8-K CURRENT REPORT 2.02,7.01,9.01 0001213900-22-071296 001-39082 221378373 34 363439 1 1
2022-11-10 10-Q QUARTERLY REPORT 0001213900-22-071154 001-39082 221377058 34 3301786 1 1
2022-10-21 SC 13G deeptrack-rlmd101322.htm 0001172661-22-002225 005-88207 221323813 34 103305
2022-10-17 SC 13G RELMADA THERAPEUTICS, INC. 0001104659-22-109334 005-88207 221313845 34 129315
2022-10-17 SC 13G SCHEDULE 13G 0000899140-22-000751 005-88207 221312437 34 59687
2022-10-13 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-22-063664 001-39082 221308226 34 226520 1 1
2022-09-23 SC 13G SC 13G 0001193125-22-250190 005-88207 221262691 34 66438
2022-09-22 8-K CURRENT REPORT 1.01,3.02,5.03,9.01 0001213900-22-058066 001-39082 221260078 34 971189 1 1
2022-09-20 8-K CURRENT REPORT 8.01,9.01 0001213900-22-057439 001-39082 221254075 34 222813 1 1
2022-08-11 10-Q QUARTERLY REPORT 0001213900-22-046934 001-39082 221156597 34 3124011 1 1
2022-07-05 4 xslF345X03/ownership.xml 0001213900-22-037231 19790
2022-06-01 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-22-030586 001-39082 22986130 34 418338 1 1
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029839 8825
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029838 5918
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029837 8831
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029835 5944
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029834 5969
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029833 8815
2022-05-26 4 xslF345X03/ownership.xml 0001213900-22-029832 5915
2022-05-05 8-K CURRENT REPORT 2.02,8.01,9.01 0001213900-22-024268 001-39082 22897349 34 5510371 1 1
2022-05-05 10-Q 10-Q 0001213900-22-024229 001-39082 22896156 34 2909582 1 1
2022-04-11 DEF 14A PROXY STATEMENT 0001213900-22-019196 001-39082 22819827 34 8574360
2022-04-07 S-3ASR REGISTRATION STATEMENT 0001213900-22-018732 333-264189 22814635 33 910021
2022-04-05 4 xslF345X03/ownership.xml 0001213900-22-018223 9235
2022-04-05 4 xslF345X03/ownership.xml 0001213900-22-018207 16134
2022-03-31 PRE 14A PROXY STATEMENT 0001213900-22-016753 001-39082 22792570 34 8573734
2022-03-25 10-K ANNUAL REPORT 0001213900-22-015012 001-39082 22768256 34 4581327 1 1
2022-03-23 8-K CURRENT REPORT 2.02,9.01 0001213900-22-014492 001-39082 22763489 34 274192 1 1
2022-03-07 8-K CURRENT REPORT 8.01,9.01 0001213900-22-010929 001-39082 22718029 34 7766301 1 1
2022-02-23 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-22-008783 001-39082 22660497 34 6218887 1 1
2022-02-14 SC 13G SC 13G 0001104659-22-022875 005-88207 22632371 34 229041
2022-02-14 SC 13G/A RELMADA THERAPEUTICS, INC. 0000902664-22-001597 005-88207 22625712 34 62549
2022-02-11 SC 13G/A RELMADA THERAPEUTICS, INC. 0000902664-22-001529 005-88207 22617374 34 61725
2022-02-03 SC 13G/A us75955j4022_020322.txt 0000834237-22-006299 005-88207 22589030 34 13430
2022-01-05 4 xslF345X03/ownership.xml 0001213900-22-000761 6987
2021-12-22 8-K CURRENT REPORT 7.01,9.01 0001213900-21-067091 001-39082 211514099 34 239003 1 1
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066825 5348
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066824 5361
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066823 5386
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066822 5355
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066821 5336
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066820 5340
2021-12-21 4 xslF345X03/ownership.xml 0001213900-21-066819 5332
2021-12-20 8-K CURRENT REPORT 8.01,9.01 0001213900-21-066436 001-39082 211506129 34 4034337 1 1
2021-12-20 SC 13G THE SCHEDULE 13G 0000921895-21-002878 005-88207 211505850 34 285895
2021-12-20 SC 13G SC 13G 0001104659-21-151724 005-88207 211505680 34 74282
2021-12-13 8-K CURRENT REPORT 1.01,9.01 0001213900-21-065014 001-39082 211488768 34 553098 1 1
2021-12-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-064733 333-245054 211485869 33 612658
2021-12-08 424B5 PROSPECTUS SUPPLEMENT 0001213900-21-064200 333-245054 211479109 33 633105
2021-12-07 8-K CURRENT REPORT 8.01,9.01 0001213900-21-063985 001-39082 211476803 34 712488 1 1
2021-11-23 8-K CURRENT REPORT 8.01,9.01 0001213900-21-061444 001-39082 211435552 34 4038407 1 1
2021-11-15 8-K CURRENT REPORT 8.01,9.01 0001213900-21-058993 001-39082 211406557 34 4354774 1 1
2021-11-12 10-Q QUARTERLY REPORT 0001213900-21-058454 001-39082 211400321 34 3493705 1 1
2021-10-07 8-K CURRENT REPORT 8.01,9.01 0001213900-21-051860 001-39082 211312943 34 4742121 1 1
2021-09-24 4 xslF345X03/ownership.xml 0001213900-21-049820 11697
2021-08-19 4 xslF345X03/ownership.xml 0001213900-21-043907 6950
2021-08-10 10-Q QUARTERLY REPORT 0001213900-21-041369 001-39082 211159845 34 3569625 1 1
2021-07-20 8-K CURRENT REPORT 1.01 0001213900-21-037756 001-39082 211101642 34 31857
2021-07-16 4 xslF345X03/ownership.xml 0001213900-21-037273 7052
2021-07-06 S-8 REGISTRATION STATEMENT 0001213900-21-035802 333-257723 211075096 33 279468
2021-06-22 4/A xslF345X03/ownership.xml 0001213900-21-033647 4444
2021-06-02 4 xslF345X03/ownership.xml 0001213900-21-030571 7051
2021-05-20 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-21-028217 001-39082 21945492 34 188478
2021-05-12 10-Q QUARTERLY REPORT 0001213900-21-025786 001-39082 21914988 34 2512206 1
2021-05-05 4 xslF345X03/ownership.xml 0001213900-21-024716 5350
2021-04-05 4 xslF345X03/ownership.xml 0001213900-21-020123 7054
2021-03-31 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-019299 001-39082 21794324 34 6281416
2021-03-24 10-K ANNUAL REPORT 0001213900-21-017556 001-39082 21769312 34 4864662 1
2021-03-23 8-K CURRENT REPORT 2.02,9.01 0001213900-21-017294 001-39082 21765101 34 94705
2021-03-15 8-K CURRENT REPORT 7.01,9.01 0001213900-21-015427 001-39082 21742501 34 27369
2021-03-15 8-K CURRENT REPORT 7.01,9.01 0001213900-21-015425 001-39082 21742450 34 25771
2021-03-11 4 OWNERSHIP DOCUMENT 0001213900-21-014918 12721
2021-03-11 4 xslF345X03/ownership.xml 0001213900-21-014917 10997
2021-03-10 4 xslF345X03/ownership.xml 0001213900-21-014656 14204
2021-03-02 4 xslF345X03/ownership.xml 0001213900-21-012891 5351
2021-02-26 4 xslF345X03/ownership.xml 0001213900-21-012174 12689
2021-02-26 4 xslF345X03/ownership.xml 0001213900-21-012171 12700
2021-02-26 4 xslF345X03/ownership.xml 0001213900-21-012169 10987
2021-02-17 4 xslF345X03/ownership.xml 0001213900-21-010148 6974
2021-02-16 4 xslF345X03/ownership.xml 0001213900-21-009699 9281
2021-02-16 4 xslF345X03/ownership.xml 0001213900-21-009696 9285
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-024243 005-88207 21639693 34 73427
2021-02-16 SC 13G/A AMENDMENT NO. 2 0001214659-21-001972 005-88207 21638639 34 81687
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023959 005-88207 21638363 34 149677
2021-02-12 SC 13G/A form-sc13ga.htm 0001493152-21-003511 005-88207 21623436 34 193327
2021-02-12 SC 13G RELMADA THERAPEUTICS, INC. 0000902664-21-001234 005-88207 21622903 34 59675
2021-02-10 4 xslF345X03/ownership.xml 0001213900-21-008204 12688
2021-02-10 4 xslF345X03/ownership.xml 0001213900-21-008203 10997
2021-02-10 4 xslF345X03/ownership.xml 0001213900-21-008202 12691
2021-02-04 4 xslF345X03/ownership.xml 0001213900-21-006837 6942
2021-02-04 4 xslF345X03/ownership.xml 0001213900-21-006834 10836
2021-02-04 4 xslF345X03/ownership.xml 0001213900-21-006832 10839
2021-02-03 4 xslF345X03/ownership.xml 0001213900-21-006570 14500
2021-02-02 4 xslF345X03/ownership.xml 0001213900-21-006210 7050
2021-02-02 SC 13G us75955j4022_020221.txt 0000834237-21-006932 005-88207 21580677 34 13402
2021-01-29 4 xslF345X03/ownership.xml 0001213900-21-005451 10983
2021-01-29 4 xslF345X03/ownership.xml 0001213900-21-005448 12499
2021-01-29 4 xslF345X03/ownership.xml 0001213900-21-005443 12694
2021-01-27 4/A OWNERSHIP DOCUMENT 0001213900-21-004515 4822
2021-01-27 4/A xslF345X03/ownership.xml 0001213900-21-004512 5694
2021-01-26 4 xslF345X03/ownership.xml 0001213900-21-004482 14394
2021-01-26 4 xslF345X03/ownership.xml 0001213900-21-004480 14380
2021-01-26 4 xslF345X03/ownership.xml 0001213900-21-004478 14381
2021-01-11 4 xslF345X03/ownership.xml 0001213900-21-001432 5296
2021-01-11 4 xslF345X03/ownership.xml 0001213900-21-001429 5350
2021-01-11 4 xslF345X03/ownership.xml 0001213900-21-001426 5325
2021-01-11 4 OWNERSHIP DOCUMENT 0001213900-21-001421 5329
2021-01-11 4 xslF345X03/ownership.xml 0001213900-21-001419 7828
2021-01-11 4 xslF345X03/ownership.xml 0001213900-21-001416 7830
2021-01-11 4 xslF345X03/ownership.xml 0001213900-21-001414 7821
2021-01-07 8-K CURRENT REPORT 8.01,9.01 0001213900-21-000805 001-39082 21513032 34 6397162
2021-01-05 8-K FORM 8-K 5.02 0001213900-21-000428 001-39082 21505354 34 17508
2021-01-05 4 xslF345X03/ownership.xml 0001213900-21-000426 5021
2020-12-14 8-K CURRENT REPORT 8.01,9.01 0001213900-20-042571 001-39082 201387045 34 4557610
2020-12-08 8-K CURRENT REPORT 8.01,9.01 0001213900-20-041596 001-39082 201375521 34 104746
2020-12-02 4 xslF345X03/ownership.xml 0001213900-20-040481 6651
2020-11-16 8-K CURRENT REPORT 8.01,9.01 0001213900-20-037155 001-39082 201313944 34 7763691
2020-11-12 10-Q QUARTERLY REPORT 0001213900-20-036542 001-39082 201306845 34 2624849 1
2020-11-03 4 xslF345X03/ownership.xml 0001213900-20-034800 5022
2020-10-27 8-K CURRENT REPORT 8.01,9.01 0001213900-20-033559 001-39082 201264724 34 36144
2020-10-02 4 xslF345X03/ownership.xml 0001213900-20-029901 5022
2020-09-02 4 xslF345X03/ownership.xml 0001213900-20-025044 6176
2020-08-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-08-21 16:00:00 9999999995-20-002225 333-245054 201124499 33 1778
2020-08-19 CORRESP filename1.htm 0001213900-20-022900 11304
2020-08-19 4 OWNERSHIP DOCUMENT 0001213900-20-022888 8664
2020-08-19 4 OWNERSHIP DOCUMENT 0001213900-20-022883 8655
2020-08-19 4 xslF345X03/ownership.xml 0001213900-20-022881 9784
2020-08-18 UPLOAD filename1.pdf 0000000000-20-007613 40316
2020-08-12 S-3 REGISTRATION STATEMENT 0001213900-20-021662 333-245054 201096282 33 514075
2020-08-12 10-Q QUARTERLY REPORT 0001213900-20-021649 001-39082 201096083 34 2621151 1
2020-08-04 4 xslF345X03/ownership.xml 0001213900-20-020143 6180
2020-07-02 4 xslF345X03/ownership.xml 0001213900-20-016524 6180
2020-06-11 SC 13G 13G 0001493215-20-000002 005-88207 20956267 34 13644
2020-06-03 8-K CURRENT REPORT 8.01,9.01 0001213900-20-013981 001-39082 20939079 34 17082334
2020-05-15 424B5 PROSPECTUS SUPPLEMENT 0001213900-20-012700 333-234262 20886987 33 468415
2020-05-15 10-Q QUARTERLY REPORT 0001213900-20-012693 001-39082 20886927 34 2859502 1
2020-04-09 4 xslF345X03/ownership.xml 0001213900-20-008907 10301
2020-04-06 8-K/A AMENDMENT TO FILED CURRENT REPORT 5.02 0001213900-20-008650 001-39082 20777303 34 20725
2020-03-26 10-KT TRANSITION REPORT 0001213900-20-007501 001-39082 20746246 34 5100378 1
2020-03-18 4 OWNERSHIP DOCUMENT 0001213900-20-006781 6700
2020-03-16 3 xslF345X02/ownership.xml 0001213900-20-006563 4385
2020-03-12 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-20-006126 001-39082 20709162 34 79066
2020-03-09 8-K CURRENT REPORT 1.01,5.07,9.01 0001213900-20-005746 001-39082 20698176 34 34111
2020-02-28 DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-20-005062 001-39082 20672341 34 30084
2020-02-14 SC 13G SC 13G 0001104659-20-021898 005-88207 20620910 34 65574
2020-02-14 SC 13G/A AMENDMENT NO. 1 - RLMD 0001214659-20-001483 005-88207 20619119 34 82822
2020-01-31 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-20-002274 001-39082 20565426 34 2581521
2020-01-10 8-K CURRENT REPORT 1.01,5.02,9.01 0001213900-20-000758 001-39082 20521228 34 302447
2020-01-07 3/A xslF345X02/ownership.xml 0001213900-20-000389 4628
2020-01-06 3 xslF345X02/ownership.xml 0001213900-20-000271 5041
2019-12-27 4 xslF345X03/ownership.xml 0001213900-19-027115 14617
2019-12-26 8-K CURRENT REPORT 5.02,5.03,8.01,9.01 0001213900-19-026923 001-39082 191308367 34 205506
2019-12-23 3 xslF345X02/ownership.xml 0001213900-19-026866 7077
2019-12-23 4 xslF345X03/ownership.xml 0001213900-19-026862 5319
2019-12-23 4 xslF345X03/ownership.xml 0001213900-19-026859 5331
2019-12-23 4 xslF345X03/ownership.xml 0001213900-19-026855 5343
2019-12-23 4 xslF345X03/ownership.xml 0001213900-19-026852 5335
2019-12-23 4 xslF345X03/ownership.xml 0001213900-19-026850 5332
2019-12-23 4 xslF345X03/ownership.xml 0001213900-19-026848 5336
2019-12-16 SC 13G SC 13G 0001104659-19-073088 005-88207 191288010 34 366250
2019-12-06 8-K CURRENT REPORT 1.01,9.01 0001213900-19-025518 001-39082 191273163 34 282048
2019-12-05 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-025441 333-234262 191271227 33 662339
2019-12-03 424B5 PROSPECTUS SUPPLEMENT 0001213900-19-025209 333-234262 191266009 33 661463
2019-12-03 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-19-025202 001-39082 191265844 34 7924546
2019-11-13 10-Q QUARTERLY REPORT 0001213900-19-023219 001-39082 191214760 34 2897633 1
2019-11-01 424B3 PROSPECTUS 0001213900-19-021807 333-229258 191186963 33 605381
2019-10-31 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2019-10-31 16:00:00 9999999995-19-002448 333-234262 191185068 33 1778
2019-10-31 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001213900-19-021146,2019-10-31 9999999995-19-002434 333-229258 191185057 33 1791
2019-10-31 SC 13G p1030190sc13g.htm 0001214659-19-006748 005-88207 191184180 34 90652
2019-10-30 CORRESP filename1.htm 0001213900-19-021477 19000
2019-10-28 CORRESP filename1.htm 0001213900-19-021295 11100
2019-10-28 S-3/A AMENDMENT NO. 1 TO FORM S-3 0001213900-19-021291 333-234262 191173859 33 331191
2019-10-25 POS AM REGISTRATION STATEMENT 0001213900-19-021146 333-229258 191169930 33 679015
2019-10-25 UPLOAD filename1.pdf 0000000000-19-014861 50964
2019-10-24 424B3 PROSPECTUS SUPPLEMENT 0001213900-19-021040 333-233228 191166837 33 1287358
2019-10-23 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-10-23 16:00:00 9999999995-19-002370 333-233228 191164694 33 1778
2019-10-21 CORRESP filename1.htm 0001213900-19-020749 8832
2019-10-21 4 xslF345X03/ownership.xml 0001213900-19-020722 4457
2019-10-21 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-19-020718 001-39082 191159764 34 3036265
2019-10-21 4 xslF345X03/ownership.xml 0001213900-19-020706 13343
2019-10-18 S-3 REGISTRATION STATEMENT 0001213900-19-020629 333-234262 191158372 33 433111
2019-10-18 8-K CURRENT REPORT 8.01,9.01 0001213900-19-020604 001-39082 191157848 34 3703142 1
2019-10-17 CORRESP filename1.htm 0001213900-19-020563 9405
2019-10-17 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-19-020561 333-233228 191155770 33 4925445 1
2019-10-16 UPLOAD filename1.pdf 0000000000-19-014620 49440
2019-10-11 CORRESP filename1.htm 0001213900-19-020213 12222
2019-10-11 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-19-020211 333-233228 191148354 33 4947476 1
2019-10-08 D xslFormDX01/primary_doc.xml 06b 0001213900-19-019994 021-350641 191143133 33 11156
2019-10-08 CERT 8A_Cert_RLMD.pdf 0001354457-19-000504 001-39082 191142202 34 86718
2019-10-08 8-A12B FORM 8-A12B 0001213900-19-019910 001-39082 191141561 34 16037
2019-10-01 8-K CURRENT REPORT 8.01,9.01 0001213900-19-019395 000-55347 191129343 34 34039
2019-09-27 8-K FORM 8-K 3.03,5.03,9.01 0001213900-19-019122 000-55347 191120725 34 259919
2019-09-24 10-K ANNUAL REPORT 0001213900-19-018787 000-55347 191110777 34 4250289 1
2019-09-23 SEC STAFF ACTION filename1.pdf 9999999997-19-007069 121164
2019-08-20 UPLOAD filename1.pdf 0000000000-19-012673 45138
2019-08-12 S-1 REGISTRATION STATEMENT 0001213900-19-015376 333-233228 191017568 33 6017603 1
2019-07-30 3 xslF345X02/ownership.xml 0001213900-19-014047 4381
2019-07-30 4 xslF345X03/ownership.xml 0001213900-19-014045 5350

Latest XBRL company facts

One latest value per concept from companyfacts (482 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 106.69M 2026-11-10 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
dei EntityPublicFloat Entity Public Float USD 18.89M 2025-06-30 2025 FY 10-K 2026-03-19 0001213900-26-031862
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 12.04M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045192
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 5.63M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045192
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 19.46M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045192
ecd PeoTotalCompAmt PeoTotalCompAmt USD 8.89M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045192
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 15.06 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001213900-26-045192
ffd NetFeeAmt NetFeeAmt USD 0 2026-05-12 S-3ASR 2026-05-13 0001213900-26-055901
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-05-12 S-3ASR 2026-05-13 0001213900-26-055901
ffd TtlOfferingAmt TtlOfferingAmt USD 50.00M 2026-05-12 S-3ASR 2026-05-13 0001213900-26-055901
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-12 S-3ASR 2026-05-13 0001213900-26-055901
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-12 S-3ASR 2026-05-13 0001213900-26-055901
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 1.5 2014-07-01 2014-12-31 2015 Q2 10-Q 2015-02-13 0001213900-15-001037
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 10,912 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 5.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 5.57M 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 100,000 2015-03-31 2015 Q3 10-Q 2015-05-15 0001213900-15-003882
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.54M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccountsPayableInterestBearingInterestRate Accounts Payable, Interest-bearing, Interest Rate pure 0.07 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccruedBonusesCurrentAndNoncurrent Accrued Bonuses USD 621,600 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 8.69M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 5.36M 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap AccruedLiabilitiesFairValueDisclosure Accrued Liabilities, Fair Value Disclosure USD 0 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 311,100 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 240,300 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 588,500 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AccruedVacationCurrentAndNoncurrent Accrued Vacation USD 395,000 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap AccumulatedAmortizationDeferredFinanceCosts Accumulated Amortization, Debt Issuance Costs USD 0 2014-06-30 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap AccumulatedCapitalizedInterestCosts Accumulated Capitalized Interest Costs USD 522,869 2018-10-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 16,700 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment, Period Increase (Decrease) USD 550 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 937.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD -59,397 2018-07-01 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 11.17M 2023-04-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 1.02M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 199,879 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.26M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap AdvertisingExpense Advertising Expense USD 5,759 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 3.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 661,168 2018-07-01 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 6.53M 2017-07-01 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 16.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap Assets Assets USD 205.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap AssetsCurrent Assets, Current USD 205.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 5.66M 2014-05-15 2014-05-20 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 100,000 2013-01-01 2013-12-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage pure 0.809 2014-05-20 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap BusinessDevelopment Business Development USD 200.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap Cash Cash USD 42.52M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 5.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -24.05M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001213900-20-012693
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 202.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 14.47M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 9.07M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 2.09M 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 2.50M 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -11.12M 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-09 0001213900-16-013088
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 0.01 2013-12-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.001 2025-11-05 2025 Q3 10-Q 2025-11-13 0001213900-25-109983
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.26M 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5,417 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 597,374 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 106.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 106.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 2.13M 2013-05-31 2013 Q3 10-Q 2013-07-12 0001255294-13-000523
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 8,500 2013-05-31 2013 Q3 10-Q 2013-07-12 0001255294-13-000523
us-gaap CommonStocksIncludingAdditionalPaidInCapital Common Stocks, Including Additional Paid in Capital USD 1.01M 2012-04-30 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap CommonStockValue Common Stock, Value, Issued USD 106,695 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ContractualObligation Contractual Obligation USD 33,000 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058454
us-gaap ContractualObligationDueAfterFifthYear Contractual Obligation, to be Paid, after Year Five USD 94,385 2016-09-30 2017 Q1 10-Q 2016-11-10 0001213900-16-018211
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 90,348 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 2.73M 2018-09-30 2019 Q1 10-Q 2018-11-13 0001213900-18-015476
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 246,747 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 2.68M 2018-10-03 2018-10-18 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 958,861 2012-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 7.21M 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 148,321 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 12,206 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap CumulativeEarningsDeficit Cumulative Earnings (Deficit) USD 424.17M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 88.61M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 11.80M 2018-10-02 2018-10-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 2.68M 2018-10-02 2018-10-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 186,727 2014-01-01 2014-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.75 2018-06-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap DebtInstrumentDecreaseForgiveness Debt Instrument, Decrease, Forgiveness USD 353,246 2012-01-01 2012-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.07 2018-10-03 2018-10-18 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.03 2015-03-31 2015 Q3 10-Q 2015-05-15 0001213900-15-003882
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.031 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 3.89M 2018-10-18 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 0 2019-12-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 78,724 2013-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 42.73M 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2017-06-30 2017 FY 10-K 2017-09-28 0001213900-17-010097
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 49.58M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 3.54M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 122.50M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 4.76M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6.20M 2017-12-22 8-K 2019-10-18 0001213900-19-020604
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 127.04M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 51.75M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 2.72M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 11,000 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 3.95M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 191,000 2017-06-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 7.76M 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.61M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 7.76M 2024-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 122.50M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD -3.95M 2018-06-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 703,720 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 118,800 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 156,700 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap Deposits Deposits USD 36.28M 2019-12-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap Depreciation Depreciation USD 1,258 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap DepreciationExpenseOnReclassifiedAssets Depreciation Expense on Reclassified Assets USD 1,258 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -54,634 2018-07-01 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap DerivativeLiabilities Derivative Liability USD 4.19M 2018-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 4.19M 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap DevelopmentInProcess Development in Process USD 200.00M 2025-03-25 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 85.16M 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap DirectOperatingCosts Direct Operating Costs USD 19.43M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap DirectTaxesAndLicensesCosts Cost, Direct Tax and License USD 7,529 2017-06-01 2017-06-08 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap DividendsShareBasedCompensation Dividend, Share-based Payment Arrangement USD 1.31M 2012-04-01 2012-04-30 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -7.16 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.44 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.102 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.026 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.022 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.02 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.052 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.008 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 8.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.155 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 12,562 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap EmployeeBenefitsAndShareBasedCompensationNoncash Employee Benefit and Share-based Payment Arrangement, Noncash USD 12,562 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 117,000 2015-09-30 2016 Q1 10-Q 2015-11-06 0001213900-15-008265
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 8.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 900,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 7.49M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap EmployeeStockOwnershipPlanESOPCompensationExpense Employee Stock Ownership Plan (ESOP), Compensation Expense USD 101,100 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap EntertainmentLicenseAgreementForProgramMaterialCapitalizedCost Entertainment, License Agreement for Program Material, Capitalized Cost USD 12.70M 2021-07-16 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.946 2014-05-20 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 13,000 2021-03-31 2021 Q1 10-Q 2021-05-12 0001213900-21-025786
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 8.82M 2021-12-08 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 1.93M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001213900-21-025786
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 0.8 2013-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0001213900-18-006121
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.916 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0001213900-18-006121
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.022 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0001213900-18-006121
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD -46.82M 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 12,562 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations USD 4,425 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap FeesAndCommissions Fees and Commissions (Deprecated 2018-01-31) USD 586,200 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD -96,403 2016-07-01 2017-06-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -66.43M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-10 0001213900-21-041369
us-gaap GainLossOnSaleOfLeasedAssetsNetOperatingLeases Gain (Loss) on Sale of Leased Assets, Net, Operating Leases USD 100,000 2017-06-01 2017-06-06 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 6.35M 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 611,382 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 6.35M 2022-01-01 2022-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 21.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap GeneralPartnersOfferingCosts General Partners' Offering Costs USD 161.23M 2022-09-30 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 3.61M 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap GrossProfit Gross Profit USD 3,396 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -125.75M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -666,708 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.35M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-07 0001213900-25-073073
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 5.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 461,515 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -3.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 812,027 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 969,641 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 512,432 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 375,533 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD 275 2011-05-23 2013-05-31 2013 Q3 10-Q 2013-07-12 0001255294-13-000523
us-gaap IncreaseDecreaseInDeferredCompensation Increase (Decrease) in Deferred Compensation USD 3,038 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001213900-25-042025
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -3,836 2016-07-01 2016-12-31 2018 Q2 10-Q 2018-02-12 0001213900-18-001597
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 54,634 2018-07-01 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option USD -26.11M 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -6,124 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap IncreaseDecreaseInLeasingReceivables Increase (Decrease) in Leasing Receivables USD -86,377 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 256,192 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-11 0001213900-22-046934
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -1,493 2016-07-01 2017-03-31 2018 Q3 10-Q 2018-05-14 0001213900-18-006121
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 6,092 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 10,912 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001213900-26-086151
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 402,430 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -637,035 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -512,432 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038533
us-gaap InterestAndOtherIncome Interest and Other Income USD 1.29M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038533
us-gaap InterestExpense Interest Expense USD 2,814 2015-07-01 2015-12-31 2016 Q2 10-Q 2016-02-05 0001213900-16-010641
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 5.15M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -706,460 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0001213900-18-006121
us-gaap InterestIncomeOther Interest Income, Other USD 2,300 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1,969 2017-07-01 2017-09-30 2017 Q1 10-Q 2017-11-14 0001213900-17-012121
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2,415 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap InterestPayableCurrent Interest Payable, Current USD 371,600 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap InterestReceivable Interest Receivable USD 566,180 2012-04-30 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 6,124 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap InventoryWriteDown Inventory Write-down USD 377 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 1.17M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 10.24M 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 15,900 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001213900-21-025786
us-gaap LeaseCost Lease, Cost USD 6,550 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap LeaseIncentiveReceivableCurrent Lease Incentive Receivable, Current USD 81,133 2021-03-31 2021 Q1 10-Q 2021-05-12 0001213900-21-025786
us-gaap LeaseIncentiveReceivableNoncurrent Lease Incentive Receivable, Noncurrent USD 65,454 2021-03-31 2021 Q1 10-Q 2021-05-12 0001213900-21-025786
us-gaap LeaseIncome Lease Income USD 2,500 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap LegalFees Legal Fees USD 79,000 2018-07-01 2019-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.084 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 11,000 2021-08-01 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 90,348 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap LessorOperatingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount USD 493,452 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 390,800 2016-03-31 2016 Q3 10-Q 2016-05-09 0001213900-16-013088
us-gaap Liabilities Liabilities USD 11.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 205.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 7,529 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001213900-17-010097
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 16,620 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001213900-17-010097
us-gaap LineOfCredit Long-term Line of Credit USD 0 2017-06-30 2017 FY 10-K 2017-09-28 0001213900-17-010097
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 975,000 2012-04-30 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap LineOfCreditFacilityIncreaseDecreaseForPeriodNet Line of Credit Facility, Increase (Decrease), Net USD 234,400 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-15 0001213900-17-005185
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 275,000 2017-03-31 2017 Q3 10-Q 2017-05-15 0001213900-17-005185
us-gaap LoansPayableCurrent Loans Payable, Current USD 900,000 2013-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap LongtermDebtPercentageBearingFixedInterestAmount Long-term Debt, Percentage Bearing Fixed Interest, Amount USD 39,990 2013-12-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 2.66M 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap LossOnSaleOfInvestments Loss on Sale of Investments USD 4.22M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap MalpracticeLossContingencyDiscountRate Malpractice Loss Contingency, Discount Rate pure 0.084 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 150.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.96M 2017-07-01 2017-09-30 2017 Q1 10-Q 2017-11-14 0001213900-17-012121
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -110.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -2,591 2017-07-01 2017-09-30 2017 Q1 10-Q 2017-11-14 0001213900-17-012121
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -37.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -979,048 2017-07-01 2017-09-30 2017 Q1 10-Q 2017-11-14 0001213900-17-012121
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -45.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -39.75M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 342,700 2015-07-01 2016-03-31 2017 Q3 10-Q 2017-05-15 0001213900-17-005185
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) USD 59,397 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 90 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058454
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap NotesPayable Notes Payable USD 0 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap NotesPayableCurrent Notes Payable, Current USD 110,247 2019-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap NumberOfReportableSegments Number of Reportable Segments segments 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OperatingExpenses Operating Expenses USD 47.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -47.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 138,600 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OperatingLeaseLeaseIncome Operating Lease, Lease Income USD 4,900 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001213900-20-012693
us-gaap OperatingLeaseLeaseIncomeLeasePayments Operating Lease, Lease Income, Lease Payments USD 397,049 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.28M 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 357,400 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 356,700 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 346,800 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 334,600 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 333,000 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 551,900 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 180,696 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 90,348 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 45,175 2019-06-30 8-K 2019-10-18 0001213900-19-020604
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 90,348 2019-12-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 90,348 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 45,174 2018-06-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 2,350 2016-09-19 2016-09-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 4.76M 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 367,800 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 69,700 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap OtherAssets Other Assets USD 11,000 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap OtherAssetsCurrent Other Assets, Current USD 256,192 2022-06-30 2022 Q2 10-Q 2022-08-11 0001213900-22-046934
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 247,379 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OtherCommitment Other Commitment USD 2.80M 2015-03-31 2015 Q3 10-Q 2015-05-15 0001213900-15-003882
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 1,258 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058454
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 129,300 2015-12-31 2016 Q2 10-Q 2016-02-05 0001213900-16-010641
us-gaap OtherExtraordinaryGainLoss Other Extraordinary Gain (Loss) (Deprecated 2019-01-31) USD 3.77M 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-13 0001213900-19-002391
us-gaap OtherGeneralExpense Other General Expense USD 1,500 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 140,914 2016-06-30 2017 FY 10-K 2017-09-28 0001213900-17-010097
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 1.80M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2,350 2017-07-01 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -623,568 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-14 0001213900-18-006121
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD 54.21M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058454
us-gaap OtherPartnersCapital Other Partners' Capital USD 100.00M 2022-04-06 2023 Q1 10-Q 2023-05-11 0001213900-23-038533
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 160,600 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap OtherReceivables Other Receivables USD 177,000 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 512,432 2022-12-31 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 905,226 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001213900-25-042025
us-gaap OtherShortTermInvestments Other Short-term Investments USD 92.23M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap PaymentsForDeposits Payments for Deposits USD 44.44M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap PaymentsForFees Payments for Other Fees USD 3.50M 2025-03-25 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 447,723 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap PaymentsForPurchaseOfInvestmentOperatingActivity PaymentsForPurchaseOfInvestmentOperatingActivity USD 250,000 2025-02-05 2025 Q3 10-Q 2025-11-13 0001213900-25-109983
us-gaap PaymentsForPurchaseOfOtherAssets1 Payments for Purchase of Other Assets USD 2.76M 2025-02-05 2025 Q3 10-Q 2025-11-13 0001213900-25-109983
us-gaap PaymentsForRent Payments for Rent USD 4,500 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 9.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 98,463 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 131,924 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 57.15M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 182.05M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD -1,800 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 199.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount Preferred Stock, Including Additional Paid in Capital, Net of Discount USD 0 2020-07-22 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap PreferredStockLiquidationPreference Preferred Stock, Liquidation Preference Per Share USD/shares 0.8 2014-06-30 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 798,094 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 537,500 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap PrepaidInsurance Prepaid Insurance USD 740,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PrepaidRent Prepaid Rent USD 9,000 2021-08-01 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap PrepaidTaxes Prepaid Taxes USD 6,000 2018-12-31 2019 Q2 10-Q 2019-02-13 0001213900-19-002391
us-gaap ProceedsFromCollectionOfLeaseReceivables Proceeds from Collection of Lease Receivables USD 50,000 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-09 0001213900-16-016664
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 42.73M 2020-05-01 2020-05-15 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 246,747 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap ProceedsFromFeesReceived Proceeds from Fees Received USD 7,529 2017-06-01 2017-06-08 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 42.73M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 160.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan Proceeds from Issuance of Common Stock, Dividend Reinvestment Plan USD 184.64M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 39,990 2004-05-25 2014-03-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 3.49M 2013-01-01 2013-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants USD 3.49M 2013-01-01 2013-12-31 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 22.23M 2014-01-01 2014-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.26M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 19.79M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-12 0001213900-21-025786
us-gaap ProceedsFromLicenseFeesReceived Proceeds from License Fees Received USD 7,529 2022-12-08 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 6.53M 2017-07-01 2018-06-30 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 3.49M 2004-05-25 2014-03-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -110,247 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap ProceedsFromSaleAndCollectionOfLeaseReceivables Proceeds from Sale and Collection of Lease Receivables USD 96,403 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 168.86M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 88.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 119,247 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 42.73M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1,683 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ProfessionalFees Professional Fees USD 25,000 2015-05-01 2015-05-31 2017 Q3 10-Q 2017-05-15 0001213900-17-005185
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -39.75M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap ProgramRightsObligationsNoncurrent Program Rights Obligations, Noncurrent USD 3.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 16,700 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1,258 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap PropertyPlantAndEquipmentOther Property, Plant and Equipment, Other, Gross USD 1,300 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD -482,284 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 512,432 2022-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap RegulatoryAssets Regulatory Assets USD 2.00M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap RelatedPartiesAmountInCostOfSales Related Parties Amount in Cost of Sales USD 13.15M 2022-08-01 2022-08-08 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 39,990 2004-05-25 2014-03-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 50,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount pure 0.01 2022-08-16 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross USD 3.98M 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationFairValueAcquired Research and Development Asset Acquired Other than Through Business Combination, Fair Value Acquired USD 3.75M 2013-07-01 2014-03-31 2015 Q3 10-Q 2015-05-15 0001213900-15-003882
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 25.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2,800 2014-07-01 2014-09-30 2015 Q1 10-Q 2014-11-07 0001213900-14-007845
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 1.93M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038533
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -744.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap RetainedEarningsAppropriated Retained Earnings, Appropriated USD 560.90M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap Revenues Revenues USD 15,602 2011-05-23 2014-02-28 2014 Q2 10-Q 2014-04-15 0001255294-14-000328
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 17 2021-12-08 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 275 2013-05-31 2013 Q3 10-Q 2013-07-12 0001255294-13-000523
us-gaap SalesTypeLeaseInitialDirectCostExpenseCommencement Sales-type Lease, Initial Direct Cost Expense, Commencement USD 213,500 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap SalesTypeLeaseSellingProfitLoss Sales-type Lease, Selling Profit (Loss) USD 96,403 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap SecuritiesPurchasedUnderAgreementsToResellIncrease Securities Purchased under Agreements to Resell, Increase USD 496,914 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 250,000 2019-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 62.39M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 3 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109983
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 157,811 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 4.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share USD/shares 1.83 2014-07-01 2015-03-31 2015 Q3 10-Q 2015-05-15 0001213900-15-003882
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.001 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 6.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 2.66 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions pure 0.039 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.141 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.135 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.045 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.041 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 74,999 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 567,911 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-07 0001213900-24-066111
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 15,040 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 930,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001213900-21-058454
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other shares 1.02M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-12 0001213900-20-021649
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 110,000 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.41M 2013-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.50M 2023-05-31 2024 Q1 10-Q 2024-05-08 0001213900-24-040856
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 16.20M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 10.80M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.69 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 4.76M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 165,939 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 19.16 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 125 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 13.05M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 487,434 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.38 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 74,999 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 15,000 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038533
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 37.92M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 15.02M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.51 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.83M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 20.36 2023-09-30 2023 Q3 10-Q 2023-11-08 0001213900-23-084737
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 11.18M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 17.42M 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 12.99 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 915,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 135,400 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 487,434 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 61,484 2019-07-01 2019-12-31 2019 FY 10-KT 2020-03-26 0001213900-20-007501
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 32.11 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.1 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 2.48 2023-11-13 2023-12-15 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 50,000 2023-03-31 2024 Q1 10-Q 2024-05-08 0001213900-24-040856
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 10 2023-03-31 2024 Q1 10-Q 2024-05-08 0001213900-24-040856
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 2.82 2023-11-13 2023-12-15 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate pure 0.98 2021-12-27 2022-01-02 2022 Q1 10-Q 2022-05-05 0001213900-22-024229
us-gaap SharePrice Share Price USD/shares 2.2 2025-11-05 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap SharesIssued Shares, Issued shares 2.80M 2022-12-21 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 7 2018-09-30 2020 Q1 10-Q 2019-11-13 0001213900-19-023219
us-gaap ShorttermDebtFairValue Short-term Debt, Fair Value USD 104.06M 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap ShortTermInvestments Short-term Investments USD 196.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap ShortTermLeasePayments Short-term Lease Payments USD 160.00M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001213900-23-064519
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 4,425 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 19,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 193.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 166.34M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap StockholdersEquityOtherShares Stockholders' Equity, Other Shares shares 166,482 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap StockIssued1 Stock Issued USD 4.50M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-08 0001213900-24-040856
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 427,700 2020-01-01 2020-06-30 2021 Q2 10-Q 2021-08-10 0001213900-21-041369
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 3.90M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 29.47M 2026-03-09 2026 Q2 10-Q 2026-08-06 0001213900-26-086151
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 19.79M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 10,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 104,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 94,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-11 0001213900-15-006928
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 1.61M 2014-12-01 2014-12-31 2016 Q2 10-Q 2016-02-05 0001213900-16-010641
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 3.02M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001213900-25-042025
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 75.00M 2020-05-01 2020-05-15 2021 Q2 10-Q 2021-08-10 0001213900-21-041369
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 11.80M 2018-07-01 2019-06-30 2020 FY 10-K 2021-03-24 0001213900-21-017556
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 1.50M 2007-01-01 2007-12-31 2014 Q3 8-K 2014-05-27 0001213900-14-003773
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 204,534 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-28 0001213900-17-010097
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 150.38M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -65,651 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-12 0001213900-26-055059
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 5,127 2012-01-01 2012-12-31 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 905,226 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.20M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 246,747 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 0.65 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001213900-25-109983
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 4.00M 2014-03-10 2014 FY 10-KT 2014-09-09 0001213900-14-006474
us-gaap SubleaseIncome Sublease Income USD 2,350 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-28 0001213900-18-013238
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 740,000 2022-10-13 2024 FY 10-K 2025-03-27 0001013762-25-003426
us-gaap TaxesAndLicenses Taxes and Licenses USD 45,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-12 0001213900-25-042025
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 1.45M 2022-09-20 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 1.45M 2022-09-20 2023 FY 10-K 2024-03-19 0001213900-24-024013
us-gaap UnearnedPremiums Unearned Premiums USD 2,300 2022-03-31 2023 Q1 10-Q 2023-05-11 0001213900-23-038533
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 290,973 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -3.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap UnrealizedLossOnSecurities Unrealized Loss on Securities USD 290,973 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense Unrecognized Tax Benefits, Income Tax Penalties Expense USD 300,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001213900-24-095398
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 6.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001213900-23-022463
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 122.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001213900-26-031862
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 0.1 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 0.001 2022-09-01 2022-09-20 2022 Q3 10-Q 2022-11-10 0001213900-22-071154
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 437,100 2020-09-30 2020 Q3 10-Q 2020-11-12 0001213900-20-036542
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 103.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 17.55M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0001213900-22-015012
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 103.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001213900-26-118916

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →